{"id":2185,"date":"2016-12-04T05:29:36","date_gmt":"2016-12-04T05:29:36","guid":{"rendered":"http:\/\/europeanvenousforum.org\/?page_id=2185"},"modified":"2016-12-16T05:46:05","modified_gmt":"2016-12-16T05:46:05","slug":"evf-larnaca-meeting-programme","status":"publish","type":"page","link":"https:\/\/europeanvenousforum.org\/index.php\/advances-in-the-management-of-chronic-venous-disorders-and-update-of-guidelines\/evf-larnaca-meeting-programme\/","title":{"rendered":"EVF Larnaca Meeting &#8211; Programme"},"content":{"rendered":"<h2 style=\"text-align: center;\"><\/h2>\n<h2 style=\"text-align: center;\"><span style=\"color: #003366;\"><strong>PROVISIONAL PROGRAM<\/strong><\/span><\/h2>\n<h3 style=\"text-align: center;\"><span style=\"color: #808080;\"><em>Click <a href=\"http:\/\/europeanvenousforum.org\/wp-content\/uploads\/2016\/12\/Flyer-Cyprus-CVD-2017.pdf\" target=\"_blank\"><strong>here<\/strong><\/a> to download the Programme<\/em><\/span><\/h3>\n<p>&nbsp;<\/p>\n<h2 style=\"text-align: center;\"><span style=\"color: #003366;\"><strong>Saturday 11 March 2017<\/strong><\/span><\/h2>\n<p>&nbsp;<\/p>\n<p><strong><span style=\"color: #800000;\">Pathophysiology, symptoms and signs<\/span><\/strong><\/p>\n<ul>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">08.00:<\/span> Welcome <em>A Nicolaides \/ Bo Eklof<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">08.15:<\/span> CEAP classification: strengths and weaknesses <em>B Eklof (Sweden)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">08.30:<\/span> Symptoms of CVD-Definitions <em>M Perrin (France)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">08.45:<\/span> Mechanism of Symptoms <em>S Kakkos (Greece)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">09.00:<\/span> Scoring of Venous Symptoms <em>JJ Guex (France)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">09.15:<\/span> The problem of C0s patients <em>M Perrin (France)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">09.30:<\/span> The diagnostic process <em>A Van Rij (New Zealand)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">09.45:<\/span> Panel Discussion<\/span><\/li>\n<\/ul>\n<p><span style=\"color: #800000;\"><strong>10.00 Coffee<\/strong><\/span><\/p>\n<p><span style=\"color: #800000;\"><strong>10.30 Key note lecture:<\/strong><\/span> <span style=\"color: #808080;\">How do duplex findings change our treatment strategies?\u00a0 When do we need additional investigations?\u00a0 <em>M De Maeseneer (Belgium)<\/em><\/span><\/p>\n<p><strong><span style=\"color: #800000;\">Varicose Veins: Effect of abolition of reflux<\/span><\/strong><\/p>\n<ul>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">10.45:<\/span> Why varicose veins produce leg ulcers?<em> A Van Rij (New Zealand)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">11.00:\u00a0<span style=\"color: #808080;\">Varicose veins arising from pelvic veins <em>TBC<\/em><\/span><\/span> <\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">11.15:<\/span> Clinical results of surgery, thermal ablation and \u201cglue\u201d. Summary of RCTs <em>B EKlof (Sweden)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">11.30:<\/span> Is UGFS from above down more effective than from down up? <em>C Hamel-Desmos (France)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">11.45:<\/span> Does compression improve comfort and results of UGFS? <em>JC Ragg (Germany)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">12.00:<\/span> Compression following saphenous ablation: a review of the data <em>A Comerota (USA)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">12.15:<\/span> Clinical results of surgery for incompetent perforating veins <em>O Nelzen (Sweden)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">12.30:<\/span> Saphenous preservation options and long term results <em>S Chastanet (France)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">12.45:<\/span> Panel discussion<\/span><\/li>\n<\/ul>\n<p><span style=\"color: #800000;\"><strong>13.00 Lunch<\/strong><\/span><\/p>\n<p><span style=\"color: #800000;\"><strong>Post-thrombotic Syndrome (PTS)<\/strong><\/span><\/p>\n<ul>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">14.00:<\/span> Can we prevent the PTS?\u00a0 <em>A Comerota (USA)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">14.15:<\/span> New Strategies for the prevention of DVT recurrence\u00a0 <em>A Nicolaides (Cyprus)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">14.30:<\/span> Compartment pressures and the value of faciotomy in PTS\u00a0 <em>JT Christenson (Switzerland)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">14.45:<\/span> The value of Endophlebectomy\u00a0 <em>A Comerota (USA)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">15.00:<\/span> Management of pelvic congestion syndrome <em>TBC<\/em><br \/>\n<\/span><\/li>\n<li><span style=\"color: #800000;\">15.15:<\/span> <span style=\"color: #808080;\">Panel discussion<\/span><\/li>\n<\/ul>\n<p><strong><span style=\"color: #800000;\">15.30 Coffee<\/span><\/strong><\/p>\n<p><span style=\"color: #800000;\"><strong>What is New in Compression<\/strong><\/span><\/p>\n<ul>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">16.00:<\/span> New experimental findings and new results from clinical trials\u00a0<em> H Partsch (Austria)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">16.15:<\/span> Increasing working compression pressure and maintaining low resting pressure\u00a0 <em>T Lundh (Sweden)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">16.30:<\/span> Intermittent pneumatic compression in CVD. Clinical and haemodynamic results\u00a0 <em>S Kakkos (Greece)<\/em><\/span><\/li>\n<\/ul>\n<p><span style=\"color: #800000;\"><strong>16.45 Keynote Lecture: <\/strong><span style=\"color: #808080;\">Compression: Principles and clinical practice <em>J Caprini (USA)<\/em><\/span><strong><br \/>\n<\/strong><\/span><\/p>\n<p><span style=\"color: #800000;\"><strong>16.30 Panel Discussion <\/strong><\/span><\/p>\n<p><span style=\"color: #800000;\"><strong>New findings in microcirculation in CVD: can abnormalities be reversed?<\/strong><\/span><\/p>\n<ul>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">17.00:<\/span> Changes in microcirculation across CEAP classes. <em>E Bouskela (Brazil)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">17.15:<\/span> Microcirculatory measurements in CVD and effect of treatment <em>A Nicolaides (Cyprus)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">17.30:<\/span> Panel discussion<\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">18.00:<\/span> Close of session<\/span><\/li>\n<\/ul>\n<h3 style=\"text-align: center;\"><\/h3>\n<h2 style=\"text-align: center;\"><span style=\"color: #003366;\"><strong>Sunday 12 March 2017<\/strong><\/span><\/h2>\n<p>&nbsp;<\/p>\n<p><span style=\"color: #800000;\"><strong>08.00 Deep venous obstruction and Reflux<br \/>\n<\/strong><\/span><\/p>\n<ul>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">08.00:<\/span> Selecting CVI patients for stenting <em>M Lugli (Italy)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">08.15:<\/span> Long term results of iliac stenting. Does original pathology matter? <em>N Baekgaard (Denmark)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">08.30:<\/span> Outcome after venous stenting: Is QoL more important than reporting PTS and patency? <em>M Gohel (UK)<br \/>\n<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">08.45:<\/span> Abolition of reflux in deep veins. Overview <em>O Maleti (Italy)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">09.00:<\/span> Who needs a neovalve? <em>M Lugli (Italy)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">09.15:<\/span> Technique of neovalve creation and long term results <em>O Maleti (Italy)<\/em><\/span><\/li>\n<\/ul>\n<p><span style=\"color: #800000;\"><strong>09.30 Keynote Lecture:<\/strong><\/span> <span style=\"color: #808080;\">Tips and tricks for successful iliac stenting (15\u2019) <em>P Neglen (Cyprus)<\/em><\/span><\/p>\n<p><span style=\"color: #800000;\"><strong>09.45 Panel discussion<\/strong><\/span><\/p>\n<p><span style=\"color: #800000;\"><strong>10.00 Coffee<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><span style=\"color: #800000;\">10.30:<\/span> Can hemodynamic tests help in the selection of patients? <em>A Nicolaides (Cyprus)<\/em><\/span><\/p>\n<p><span style=\"color: #808080;\"><span style=\"color: #800000;\">10.45:<\/span> The ideal venous stent <em>A Giannoukas (Greece)<\/em><\/span><\/p>\n<p><span style=\"color: #800000;\"><strong>Update on thrombolysis for DVT<\/strong><\/span><\/p>\n<ul>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">11.00:<\/span> Thrombolysis\/thrombectomy: results and guidelines\u00a0 <em>A Comerota (USA)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">11.15:<\/span> Should we measure thrombus age prior to thrombolysis?\u00a0 <em>N Baekgaard (Denmark)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">11.30:<\/span> Anticoagulation or catheter lysis: Which is more cost-effective?\u00a0 <em>M Husmann (Switzerland)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">11.45:<\/span> Panel Discussion<\/span><\/li>\n<\/ul>\n<p><strong><span style=\"color: #800000;\">Pharmacotherapy in patients with CVD<\/span> <\/strong><\/p>\n<ul>\n<li><span style=\"color: #808080;\"><span style=\"color: #800000;\">12.00:<\/span> Classification and pharmacological action\u00a0 <em>E Bouskela (Brazil)<\/em><\/span><em>\u00a0\u00a0<\/em><\/li>\n<\/ul>\n<p><span style=\"color: #800000;\"><strong>12.15 Effect on symptoms and healing of venous ulcers:<\/strong><\/span><\/p>\n<ul>\n<li><span style=\"color: #808080;\">Daflon-500 <em>M Perrin (France)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\">Ruscus + HMC + Vit C <em>AF Allaert (France)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\">Pentoxyphilline <em>S Kakkos (Greece)<\/em><br \/>\n<\/span><\/li>\n<li><span style=\"color: #808080;\">Sulodexide <em>A Nicolaides (Cyprus)<\/em><\/span><\/li>\n<li><span style=\"color: #808080;\">Other <em>TBC<\/em><\/span><\/li>\n<\/ul>\n<p><span style=\"color: #800000;\"><strong>13.15 Lunch<\/strong><\/span><\/p>\n<p><span style=\"color: #800000;\"><strong>14.00 Delegates depart<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><strong>Faculty meeting to consider and discuss draft updated guidelines on CVD previously drafted in 2013 and published in 2014.<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><span style=\"color: #800000;\">14.30:<\/span> Chapters 1-7 <\/span><\/p>\n<p><span style=\"color: #800000;\"><strong>16.30: Coffee<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><span style=\"color: #800000;\">17.00 \u2013 18.30:<\/span> Chapters 8-12<\/span><\/p>\n<h3 style=\"text-align: center;\"><\/h3>\n<h2 style=\"text-align: center;\"><span style=\"color: #003366;\"><strong>Monday 13 March 2017<\/strong><\/span><\/h2>\n<p>&nbsp;<\/p>\n<p><span style=\"color: #808080;\"><strong>09.00 Faculty meeting to consider and discuss draft updated guidelines on CVD previously drafted in 2013 and published in 2014 (Continued)<\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\">Chapters 13-20<\/span><\/p>\n<p><span style=\"color: #800000;\"><strong>13.00: Lunch\u00a0 <\/strong><\/span><\/p>\n<p><span style=\"color: #808080;\"><span style=\"color: #800000;\">14.00:<\/span> Faculty Departs<\/span><strong><br \/>\n<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PROVISIONAL PROGRAM Click here to download the Programme &nbsp; Saturday 11 March 2017 &nbsp; Pathophysiology, symptoms and signs 08.00: Welcome A Nicolaides \/ Bo Eklof 08.15: CEAP classification: strengths and weaknesses B Eklof (Sweden) 08.30: Symptoms of CVD-Definitions M Perrin (France) 08.45: Mechanism of Symptoms S Kakkos (Greece) 09.00: Scoring \u2026 <a class=\"continue-reading-link\" href=\"https:\/\/europeanvenousforum.org\/index.php\/advances-in-the-management-of-chronic-venous-disorders-and-update-of-guidelines\/evf-larnaca-meeting-programme\/\"> Continue reading <span class=\"meta-nav\">&rarr; <\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":1857,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-onecolumn.php","meta":{"_exactmetrics_skip_tracking":false,"ngg_post_thumbnail":0,"footnotes":""},"class_list":["post-2185","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/pages\/2185","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/comments?post=2185"}],"version-history":[{"count":8,"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/pages\/2185\/revisions"}],"predecessor-version":[{"id":2235,"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/pages\/2185\/revisions\/2235"}],"up":[{"embeddable":true,"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/pages\/1857"}],"wp:attachment":[{"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/media?parent=2185"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}